Partnering with HCPs and KOLs for paid engagements such as advisory boards and speaker events is a key strategy for life science companies, however the DOJ and OIG have repeatedly said they are skeptical of the value of these interactions. So, how does the industry accelerate these valuable engagements while remaining compliant and out of trouble with enforcers?
Listen as MediSpend’s Chief Commercial Officer, Seth Houston, and MediSpend’s Director of Solutions Engineering, Matt Baillargeon, demonstrate an efficient approach to compliantly plan, engage and pay HCP/Os, while meeting all company policies and compliance regulations using intuitive technology.
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.